These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 8847874
1. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H. J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874 [Abstract] [Full Text] [Related]
2. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia. Farnier M, Bonnefous F, Debbas N, Irvine A. Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177 [Abstract] [Full Text] [Related]
3. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study. Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM. Endocr Pract; 2002 Feb 28; 8(2):96-101. PubMed ID: 11942772 [Abstract] [Full Text] [Related]
4. Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia. Raslová K, Dubovská D, Mongiellová V, Trnovec T. Eur J Clin Pharmacol; 1997 Feb 28; 52(2):101-6. PubMed ID: 9174678 [Abstract] [Full Text] [Related]
5. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Bruckert E, De Gennes JL, Malbecq W, Baigts F. Clin Cardiol; 1995 Nov 28; 18(11):621-9. PubMed ID: 8590530 [Abstract] [Full Text] [Related]
6. Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study. Ansquer JC, Bekaert I, Guy M, Hanefeld M, Simon A, Study Investigators. Am J Cardiovasc Drugs; 2009 Nov 28; 9(2):91-101. PubMed ID: 19331437 [Abstract] [Full Text] [Related]
9. The fibrates in clinical practice: focus on micronised fenofibrate. Shepherd J. Atherosclerosis; 1994 Oct 28; 110 Suppl():S55-63. PubMed ID: 7857386 [Abstract] [Full Text] [Related]
10. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. Stohler R, Keller U, Riesen WF. Eur J Clin Pharmacol; 1989 Oct 28; 37(2):199-203. PubMed ID: 2507323 [Abstract] [Full Text] [Related]
14. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia. Crook D, Bruce R, Worthington M, Mulcahy D, Patterson D, Wynn V. Cardiovasc Drugs Ther; 1992 Dec 28; 6(6):633-9. PubMed ID: 1292582 [Abstract] [Full Text] [Related]
15. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. Frost RJ, Otto C, Geiss HC, Schwandt P, Parhofer KG. Am J Cardiol; 2001 Jan 01; 87(1):44-8. PubMed ID: 11137832 [Abstract] [Full Text] [Related]
16. Comparison of the efficacy and safety of fenofibrate and lovastatin in patients with primary type IIa or IIb hyperlipidaemia. Gholami K, Tavakoli N, Maleki M, Shafiee A. J Clin Pharm Ther; 1998 Jun 01; 23(3):213-21. PubMed ID: 9831973 [Abstract] [Full Text] [Related]
18. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia. Thiery J, Creutzfeldt C, Creutzfeldt W, Walli AK, Seidel D. Klin Wochenschr; 1990 Aug 17; 68(16):814-22. PubMed ID: 2214604 [Abstract] [Full Text] [Related]